SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change? (2021)

First Author: Alexander JL
Attributed to:  King's Health Partners Confidence in Concept funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2468-1253(21)00184-9

PubMed Identifier: 34048723

Publication URI: http://europepmc.org/abstract/MED/34048723

Type: Journal Article/Review

Volume: 6

Parent Publication: The lancet. Gastroenterology & hepatology

Issue: 7